Aldeyra Therapeutics to Present at the Stifel 2015 Healthcare Conference
November 10, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Nov. 10, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Schedules Webcast and Conference Call for Third Quarter 2015 Financial and Operating Results
November 05, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Announces First Patient Enrolled in Allergic Conjunctivitis Phase IIa Clinical Trial
September 29, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Sept. 29, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics to Present Novel Data on a Potential Treatment for Succinic Semi-Aldehyde Dehydrogenase Deficiency at the 2015 American Society of Human Genetics (ASHG) Annual Meeting
September 09, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Sept. 9, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Reports Second Quarter and Year to Date 2015 Financial Results and Provides Development Updates
August 11, 2015 07:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Aug. 11, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference
August 05, 2015 16:15 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Aug. 5, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Schedules Webcast and Conference Call for Second Quarter 2015 Financial Results
July 28, 2015 16:15 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., July 28, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics to Ring the Nasdaq Stock Market Closing Bell
June 29, 2015 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., June 29, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Announces Closing of Common Stock Offering
May 22, 2015 16:15 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., May 22, 2015 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Reports First Quarter 2015 Financial and Operating Results
May 13, 2015 07:30 ET
|
Aldeyra Therapeutics
Initiated Two Phase II Clinical Trials and Secured $9.0 Million In Net Proceeds Through Two Private Placements In Q1
Follow-On Public Offering Resulting in $18.8 Million In Net Proceeds Expected...